Naltrexone for the Treatment of Darier and Hailey-Hailey Diseases

Abstract

Keywords

Darier disease (DD)Hailey-Hailey disease (HHD)low-dose naltrexone (LDN)naltrexone

Get full access to this article

View all access options for this article.

References

Lee

Elston

. The uses of naltrexone in dermatological conditions [published online ahead of print December 21, 2018]. J Am Acad Dermatol. doi:10.1016/j.jaad.2018.12.031

Boehmer

Eyerich

Darsow

Biedermann

Zink

. Variable response to low-dose naltrexone in patients with Darier disease: a case series [published online ahead of print February 3, 2019]. J Eur Acad Dermatol Venereol. doi:10.1111/jdv.15457

Kellermayer

Szigeti

Keeling

Bedekovics

Bedwell

. Aminoglycosides as potential pharmacogenetic agents in the treatment of Hailey-Hailey disease. J Invest Dermatol. 2006;126(1):229-231. doi:10.1038/sj.jid.5700031

Younger

Parkitny

McLain

. The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clin Rheumatol. 2014;33(4):451-459. doi:10.1007/s10067-014-2517-2

Cao

Lilly

Chen

. Variable response to naltrexone in patients with Hailey-Hailey disease. JAMA Dermatol. 2018;154(3):362-363. doi:10.1001/jamadermatol.2017.5463